Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 213079
Company: PADAGIS ISRAEL
Company: PADAGIS ISRAEL
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
TAZAROTENE | TAZAROTENE | 0.05% | GEL;TOPICAL | Prescription | AB | No | No |
TAZAROTENE | TAZAROTENE | 0.1% | GEL;TOPICAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/25/2023 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
TAZAROTENE
GEL;TOPICAL; 0.05%
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
TAZAROTENE | TAZAROTENE | 0.05% | GEL;TOPICAL | Prescription | No | AB | 215433 | COSETTE |
TAZAROTENE | TAZAROTENE | 0.05% | GEL;TOPICAL | Prescription | No | AB | 213079 | PADAGIS ISRAEL |
TAZAROTENE | TAZAROTENE | 0.05% | GEL;TOPICAL | Prescription | No | AB | 213644 | SOLARIS PHARMA CORP |
TAZORAC | TAZAROTENE | 0.05% | GEL;TOPICAL | Prescription | Yes | AB | 020600 | ALLERGAN |
GEL;TOPICAL; 0.1%
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
TAZAROTENE | TAZAROTENE | 0.1% | GEL;TOPICAL | Prescription | No | AB | 214136 | COSETTE |
TAZAROTENE | TAZAROTENE | 0.1% | GEL;TOPICAL | Prescription | No | AB | 213079 | PADAGIS ISRAEL |
TAZAROTENE | TAZAROTENE | 0.1% | GEL;TOPICAL | Prescription | No | AB | 213644 | SOLARIS PHARMA CORP |
TAZORAC | TAZAROTENE | 0.1% | GEL;TOPICAL | Prescription | Yes | AB | 020600 | ALLERGAN |